Pharma Works

Bluebird resumes marketing of gene therapy in Europe

Dive brief: Bluebird bio, a pharmaceutical company based in Cambridge, Massachusetts, announced on Friday that it would resume sales of one of its gene therapies in Europe after voluntarily halting marketing in February over safety concerns. Known as Zynteglo, the treatment was conditionally approved in Europe about two years ago …

Read More »

Mid-Year Trends in Intellectual Property Law 2021: Looking Ahead

Practitioners are eagerly monitoring court cases for several intellectual property-related cases in the second half of 2021 that promise to make an impact. These decisions are expected to provide guidance in several areas of intellectual property law, including patent eligibility, creation of AI-generated inventions, and pharmaceutical labeling. Indeed, a most …

Read More »